Stomach cancer trial combines chemo with Bug-Fighting therapy

NCT ID NCT06510010

Recruiting now Disease control Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University Source: ClinicalTrials.gov ↗

First seen Feb 01, 2026 · Last updated May 16, 2026 · Updated 14 times

Summary

This study tests whether adding treatment for H. pylori infection to standard chemotherapy (oxaliplatin and S-1) before and after surgery can help shrink tumors more effectively in people with locally advanced stomach or gastroesophageal junction cancer. About 198 participants with H. pylori-positive, resectable cancer will be randomly assigned to receive either chemotherapy alone or chemotherapy plus H. pylori eradication. The main goal is to see if the combination leads to a major reduction in tumor size at the time of surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY EFFECT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

The Sixth Affiliated Hospital，Sun Yat-sen University
RECRUITING

Guangzhou, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CHEMOTHERAPY EFFECT